Savara Inc (SVRA)
Healthcare
Biotechnology
5.50 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Savara Inc (SVRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -101 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25 | -33 | -8.4 | -28 | -39 | -45 | -40 | -40 | -35 | -51 | -89 | -101 | |
| 0.1 | 0.1 | 0.3 | 0.4 | 0.5 | 1.0 | 0.7 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | |
| 2.0 | 2.7 | 0.2 | 0.6 | 3.7 | 4.4 | 5.1 | 3.3 | 2.0 | 4.2 | 9.9 | 14 | |
| 1.5 | 2.7 | 6.3 | 2.3 | 19 | 32 | 10 | 4.9 | – | – | – | – | |
| 2.4 | 3.9 | 1.5 | -2.0 | 2.4 | 0.8 | -1.7 | -2.8 | 1.0 | 4.1 | 1.8 | 5.0 | |
| 0.1 | 0.2 | 0.0 | 0.5 | 0.1 | 0.1 | 3.3 | 0.1 | 0.0 | 0.3 | 0.0 | 0.0 | |
| 0.5 | 3.4 | 0.0 | -69 | -14 | 16 | 9.1 | -69 | 53 | -57 | -40 | -18 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | 2.1 | – | – | – | – | – | |
| 34 | 2.0 | 19 | 91 | 46 | 55 | 2.1 | -0.1 | 0.0 | -1.2 | -1.0 | -5.1 | |
| 10 | 15 | -12 | 14 | 8.8 | 0.0 | -0.5 | 0.0 | 0.1 | 0.0 | 0.0 | 2.4 | |
| 34 | 17 | 5.1 | 106 | 55 | 55 | 3.7 | 121 | 0.1 | 83 | 118 | 138 | |
| 10 | -13 | -3.3 | 8.7 | 2.2 | 26 | -27 | 11 | 18 | -26 | -11 | 18 | |
| -25 | -33 | -8.4 | -29 | -39 | -45 | -43 | -40 | -35 | -51 | -89 | -101 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.